About Spotlight Therapeutics
Spotlight Therapeutics is a company based in Hayward (United States) founded in 2017. Spotlight Therapeutics has raised $80.67 million across 5 funding rounds from investors including HHS, EPIQ and GordonMD Global Investments. The company has 32 employees as of December 31, 2022. Spotlight Therapeutics operates in a competitive market with competitors including Senti Biosciences, Beam Therapeutics, eGenesis, Annexon and TScan Therapeutics, among others.
- Headquarter Hayward, United States
- Employees 32 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spotlight Therapeutics Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$80.67 M (USD)
in 5 rounds
-
Latest Funding Round
$533.94 K (USD), Grant
Sep 21, 2023
-
Investors
HHS
& 5 more
-
Employee Count
32
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Spotlight Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Spotlight Therapeutics
Spotlight Therapeutics has successfully raised a total of $80.67M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $533.94 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spotlight Therapeutics
Spotlight Therapeutics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, EPIQ and GordonMD Global Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are provided in the biopharmaceutical sector.
|
Locked | Locked | Locked | |
|
Diversified asset management services are offered by EPIQ.
|
Locked | Locked | Locked | |
|
Magnetic Ventures is focused on transforming healthcare through AI and biotech investments.
|
Locked | Locked | Locked |
Investor details for Spotlight Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spotlight Therapeutics
Investment portfolio details for Spotlight Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spotlight Therapeutics
Detailed financials for Spotlight Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spotlight Therapeutics Comparisons
Peer comparison for Spotlight Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spotlight Therapeutics
Spotlight Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Beam Therapeutics, eGenesis, Annexon and TScan Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell-based therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| Locked | Locked | Locked |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| Locked | Locked | Locked |
CAR-T and TIL immunotherapies for solid tumors are developed.
|
Detailed competitors of Spotlight Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spotlight Therapeutics
Complete news archive for Spotlight Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spotlight Therapeutics
Spotlight Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Spotlight Therapeutics is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Spotlight Therapeutics is a funded company, having raised a total of $80.67M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Spotlight Therapeutics is 32.
Founded in 2017 and based in Hayward, United States, the company focuses on biotechnology in the oncology sector. Cancer therapeutics are developed through a proprietary platform called TAGE, by which CRISPR nuclease effectors are delivered to selected cells in vivo. A pipeline is maintained for applications in immuno-oncology, hematology, and ophthalmology, with operations centered on advancing gene editing technologies for therapeutic use.
Spotlight Therapeutics's top competitors include Hummingbird Bioscience, Lyell Immunopharma and eGenesis.
Spotlight Therapeutics has 6 investors. Key investors include HHS, EPIQ, GordonMD Global Investments, Magnetic Ventures, and Google Ventures.